Literature DB >> 4969311

Desacetyl-rifamycins: preparation and antibacterial properties.

N Maggi, A Vigevani, R Pallanza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4969311     DOI： 10.1007/BF02152772

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  6 in total

1.  [RIFOMYCIN. CHEMICAL AND CHEMICO-PHYSICAL PROPERTIES OF RIFOMYCIN B DIETHYLAMIDE].

Authors:  N MAGGI; G G GALLO; P SENSI
Journal:  Farmaco Prat       Date:  1965-03

2.  New derivatives of rifamycin SV.

Authors:  N Maggi; R Pallanza; P Sensi
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

3.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

4.  Synthesis of 3-formylrifamycin SV.

Authors:  N Maggi; G G Gallo; P Sensi
Journal:  Farmaco Sci       Date:  1967-05

5.  RIFAMYCINS. XXXV. AMIDES AND HYDRAZIDES OF RIFAMYCIN B3.

Authors:  P SENSI; N MAGGI; R BALLOTTA; S FUERESZ; R PALLANZA; V ARIOLI
Journal:  J Med Chem       Date:  1964-09       Impact factor: 7.446

6.  Rifamycins. XLI. A new class of active semisynthetic rifamycins. N-substituted aminomethyl derivatives of rifamycin SV 2.

Authors:  N Maggi; V Arioli; P Sensi
Journal:  J Med Chem       Date:  1965-11       Impact factor: 7.446
  6 in total
  2 in total

1.  Assay of rifampicin in serum.

Authors:  J M Dickinson; V R Aber; B W Allen; G A Ellard; D A Mitchison
Journal:  J Clin Pathol       Date:  1974-06       Impact factor: 3.411

2.  Systemic absorption of rifamycin SV MMX administered as modified-release tablets in healthy volunteers.

Authors:  A F D Di Stefano; A Rusca; L Loprete; M J Dröge; L Moro; A Assandri
Journal:  Antimicrob Agents Chemother       Date:  2011-03-14       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.